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Background: Sequential accumulation of M1 and M2 macrophages is critical for skeletal muscle recovery after an
acute injury. While M1 accumulation is believed to rely on monocyte infiltration, the mechanisms of M2 accumulation
remain controversial, but could involve an infiltrating precursor. Yet, strong depletion of monocytes only partially
impairs skeletal muscle healing, supporting the existence of alternative mechanisms to palliate the loss of infiltrating
macrophage progenitors. The aims of this study are thus to investigate if proliferation occurs in macrophage subsets
within injured skeletal muscles; and to determine if monocyte depletion leads to increased proliferation of
macrophages after injury.
Methods: Injury was induced by bupivacaine injection in the tibialis anterior muscle of rats. Blood monocytes were
depleted by daily intravenous injections of liposome-encapsulated clodronate, starting 24 h prior to injury. In separate
experiments, irradiation of hind limb was also performed to prevent resident cell proliferation. Upon euthanasia, blood
and muscles were collected for flow cytometric analyses of macrophage/monocyte subsets.
Results: Clodronate induced a 80%-90% depletion of monocyte but only led to 57% and 41% decrease of M1 and
M2 macrophage accumulation, respectively, 2 d following injury. Conversely, the number of M1 macrophages in
monocyte-depleted rats was 2.4-fold higher than in non-depleted rats 4 d after injury. This was associated with a
16-fold increase in the number of proliferative M1 macrophages, which was reduced by 46% in irradiated animals.
Proliferation of M2 macrophages was increased tenfold by clodronate treatment 4 d post injury. The accumulation
of M2 macrophages was partially impaired by irradiation, regardless of monocyte depletion.
Conclusions: M1 and M2 subsets proliferate after skeletal muscle injury and their proliferation is enhanced under
condition of monocyte depletion. Our study supports the conclusion that both infiltrating and resident precursors
could contribute to M1 or M2 macrophage accumulation in muscle injury.
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Macrophages are classically known for their pro-inflam-
matory roles in innate immunity and more recently for
their active contribution to the resolution of inflammation
and tissue repair [1-6]. This versatility is reflected by their
ability to adopt distinct phenotypes depending on the
microenvironment [7-9]. Macrophages can be divided in
two main subsets according to their mode of activation
and specific functions. In the context of skeletal muscle* Correspondence: elise1_duchesne@uqac.ca
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reproduction in any medium, provided the ortissue injury, “classically activated” [10] M1 macrophages
are found during the inflammatory phase and are associ-
ated with phagocytosis, while “alternatively activated” [10]
M2 macrophages accumulate at the site of injury once
necrotic tissue has been removed and participate to the
repair and remodeling processes [7-9]. In rats, former
nomenclature ED1+ and ED2+ refers to M1 (CD68+
CD163-) and M2 (CD68+ CD163+) macrophage subsets,
respectively. For the sake of clarity we will thereafter
refer to M1 and M2 macrophages. Macrophages insuring
homeostasis of uninjured muscles are believed to be
resident cells and would present a M2 phenotype [7,9].
Macrophage involvement is clearly a prerequisite for
skeletal muscle repair and their deregulation can determined. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is that macrophages must freely accumulate in the injured
muscle to ensure an adequate healing [1-3,11-13]. However,
depletion of macrophages has only led to partial alteration
of skeletal muscle recovery after injury [3], [1], supporting
the existence of alternative mechanisms to ensure the
functions of macrophages. Given the critical involve-
ment of macrophage subsets in skeletal muscle healing,
a better understanding of the mechanisms governing
their accumulation may reveal new points of regulation
for intervention.
The mechanisms of M1 and M2 macrophage accumu-
lation after sterile injury remain elusive. In models like
peritoneal infection, M1 or M2 macrophage accumulation
results from the differentiation of distinct infiltrating M1
and M2 myeloid precursors [14]. In contrast, recent
evidences support in situ proliferation of M1 and M2
macrophage subsets in TH2-mediated inflammation
[14,15]. In the context of muscle injury, M1 macrophage
accumulation is thought to result exclusively from the
infiltration and differentiation of a precise monocyte
subset into macrophages. On the other hand, the origin
of the increased number of M2 macrophages is a matter
of debate. A number of hypotheses are currently put
forward including sequential mobilization of M1 and M2
macrophage circulating precursors [16], differentiation of
monocyte-derived M1 macrophages into M2 macrophages
following phagocytic activity after skeletal muscle injury
[2] or M2 macrophage proliferation [15]. It appears that the
mechanisms of M1 and M2 accumulation in this specific
situation are complex, sometimes overlapping, and most
likely determined by the context of the immune response.
The importance of sequential accumulation of M1 and
M2 macrophages for optimal muscle healing is now
well accepted. However, the cellular origin and respective
contribution of proliferation vs. infiltration remain elusive
following skeletal muscle injury. In addition, there is no
information on how those mechanisms might be altered
under anti-inflammatory conditions. The goal of this study
was to determine if local proliferation could contribute
to M1 and M2 macrophage accumulation following
skeletal muscle injury, under normal or monocyte depletion
conditions. Given that M1 macrophage accumulation in
the context of sterile skeletal muscle injury is believed to
rely exclusively on monocyte infiltration [2,16], and that
M2 macrophage accumulation could be derived from M1
[2], our working hypothesis is that following sterile muscle
injury in rat, blood monocyte depletion will impair M1
and M2 tissue macrophage accumulation.
Methods
Animals
Female Wistar rats weighing between 125 – 150 g were
purchased from Charles River (St-Constant, QC, Canada)and housed 3 per cage. They were maintained on a 12 h –
12 h light – dark cycle. Water and food were provided
ad libitum. All care, handling and experimental proce-
dures were approved by the Université Laval Research
Center Animal Care (Permit Number: 2012–025) and Use
Committee according to the guidelines of the Canadian
Council on Animal Care.
Muscle injury
At 0 d, the right tibialis anterior (TA) muscle was chemi-
cally injured with bupivacaine. Rats received 0.05 mg/kg
buprenorphine (Temgesic®, Reckitt Benckiser Healthcare
(UK) Ltd) intraperitoneally (i.p.) as an analgesic 15 min
before surgery and were then anesthetized with 1.5 – 2%
isoflurane (Abbott Laboratories, Montreal, QC, Canada)
under a flow of 400 – 800 mL/min of oxygen. Fur of the
anterior side of the right hind limb was shaved off and
skin was disinfected with isopropyl alcohol. Then, 120
μL of bupivacaine hydrocloride 0.5% (Marcaine; Hospira,
Lake Forest, IL, USA) was injected through the skin in 3
sites of 40 μL along the right TA using a syringe with a 29
G needle. A single dose of 0.05 mg/kg of buprenorphine
was also administrated i.p. 1 d after the injury.
Monocyte depletion
Liposome-encapsulated dichloromethylene diphosphonate
(Cl2MDP; clodronate) was used to deplete blood mono-
cytes/macrophages [17]. Clodronate was a gift from Roche
Diagnostics GmbH (Mannheim, Germany). Rats received
1 mL, at the concentration established by the provider, of
the liposome-encapsulated clodronate suspension. Injec-
tions were made daily in the tail vein or in the internal
jugular veins under anesthesia with isoflurane starting 24 h
before injury until sacrifice at 1, 2, 3 or 4 d post-injury.
Single leg irradiation
Liposome-encapsulated clodronate does not deplete resi-
dent macrophages in muscle. To study the contribution of
resident macrophages, irradiation was performed since it
prevents proliferation by inducing DNA damage, especially
in immune cells [18,19]. 24 h before injury, rats were anes-
thetized by i.p. injection of a ketamine/xylazine cocktail (80
mg/kg ketamine and 10 mg/kg xylazine) and then installed
under a 4 cm-thick lead shield plate with their right hind
limb facing a hole allowing radiation to pass for local
irradiation. The right leg received a single dose of 20 Gy of
γ rays delivered at 1.1 Gy per minute using a Gammacell®
40 Exactor (Best Theratronics Ltd, Ottawa, ON, Canada).
This dose prevents resident leukocyte replication without
killing mature muscle cells [18,20-23].
Isolation of peripheral blood mononuclear cells (PBMCs)
5 mL of blood was obtained by cardiac puncture under
anesthesia with isoflurane and collected in BD VacutainerW
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Lakes, NJ, USA). PBMCs were isolated with a density-
gradient centrifugation on Histopaque 1083 (Sigma-
Aldrich, St. Louis, MO, USA). Blood was deposited on
3 mL of Histopaque 1083 in a 15 mL conical tube and
centrifuged for 30 min at 400 × g at room temperature.
The upper layer was discarded and the opaque interface
containing mononuclear cells (buffy coat) was aspirated
with a Pasteur pipette and transferred to a new 15 mL
centrifuge tube. Cells were washed twice with PBS and
contaminating erythrocytes were lysed with a 4 min
incubation with 1 mL of sterile erythrocyte lysis buffer
containing 155 mM NH4Cl, 10 mM KHCO3 and 0.342
mM EDTA. 10 mL of PBS was then added to stop the
lysis. After washing twice with PBS, cells were resuspended
in 0.5 mL PBS and counted with a hemocytometer using
trypan blue exclusion.
Preparation of single cell suspension from TA muscle
Rats were euthanized by cervical dislocation under
anesthesia with isoflurane. TA muscles were dissected
and rinsed in PBS. Minced muscles were incubated for
3 h at 37°C with 5 mL of Roswell Park Memorial
Institute media 1640 (RPMI 1640) (HyClone, Logan,
UT, USA) containing 3 mg/mL collagenase D (Roche
Diagnostics, Laval, QC, Canada). Collagenase-digested
samples were then homogenized by trituration using a
1000 μL micropipette. 10 mL PBS-EDTA (26 mM EDTA
in PBS) was added to this suspension and centrifuged
at 500 × g for 5 min at 4°C. After red blood cell lysis,
the pellet was resuspended in 30% isotonic Percoll
(GE healthcare, Waukesha, WI, USA) and centrifuged at
500 × g for 15 min at 4°C. The supernatant was discarded
and the pellet resuspended in 1 mL PBS-EDTA. Cells
were counted with a hemocytometer using trypan blue
exclusion.
Flow cytometric analyses
Sequential extracellular and intracellular stainings were
performed as described earlier [24]. Single cell suspensions
were washed in staining buffer (PBS containing 2% FBS).
Cells were then resuspended in staining buffer containing
Fc Block (anti-CD32) (BD Biosciences, Mississauga, ON,
Canada). A cocktail of antibodies containing Pacific Blue-
coupled anti-CD11b (Serotec, Kidlington, UK), biotin-
coupled anti-CD3 (Serotec, Kidlington, UK), biotin-coupled
anti-CD45RA (Biolegend, San Diego, CA, USA), Alexa
Fluor® 647-coupled anti-CD163 (Serotec, Kidlington,
UK) or Alexa Fluor® 647 coupled-IgG1 isotype control
(Serotec, Kidlington, UK) was added to the cell suspension
and incubated for 20 min on ice. Cells were washed
in staining buffer and incubated with Alexa Fluor®
700-coupled streptavidin (Invitrogen Life Technologies,
Burlington, Canada) for 20 min on ice. Cells were washedin staining buffer and fixed in PBS containing 2% parafor-
maldehyde for 20 min on ice, and then permeabilized in
staining buffer containing 0.2% saponin for staining with
anti RPE-coupled anti-CD68 (Serotec, Kidlington, UK) and
Pe-Cy7-coupled anti-Ki-67 (BD Biosciences, Mississauga,
ON, Canada) or RPE-coupled IgG1 isotype control
(Serotec, Kidlington, UK) and Pe-Cy7-coupled k IgG1 iso-
type control (BD Biosciences, Mississauga, ON, Canada).
Intracellular staining was performed for 30 min on ice.
Single color controls were performed using CompBead
Plus (BD Biosciences, Mississauga, ON, Canada). Data
was acquired with a FACS Diva-driven FACS Aria II
(Becton Dickinson) and analyzed with FlowJo (Tree Star
Inc. Ashland, OR, USA). Isotype controls or omission of
primary antibodies (when appropriate) were used to set
gates. To determine numbers of specific cell subsets
(from blood or skeletal muscles), the percentages ob-
tained from flow cytometric analyses were multiplied
by the absolute cell numbers obtained from the hemo-
cytometer count.
Statistical analysis
All values are expressed as means and standard error.
The construct of these experiments allowed comparisons
between groups to be performed by Student’s t-test or
one-way ANOVA followed by Tukey-Kramer post-hoc
test, when appropriate (InStat GraphPad Software Inc.,
La Jolla, CA, USA). Significance was defined as p < 0.05.
Results
Blood monocyte depletion modifies macrophage
accumulation in injured muscle
Before assessing the contribution of blood monocyte
infiltration to the accumulation of macrophages in injured
muscle, we validated that daily liposome-encapsulated
clodronate injection led to profound blood monocyte
depletion. Blood monocytes correspond to the population
negative for lymphocyte markers CD3 and CD45RA, but
positive for myeloid marker CD11b and the monocyte/
macrophage marker CD68 (Figure 1A). We used values
obtained at 4 d post-injury to demonstrate that when
compared with uninjured animals that contain 20.9% of
non-lymphoid CD3-CD45RA- circulating cells, muscle
injury slightly decreased this frequency to 16.1%, while
clodronate treatment lowered the frequency of CD3-
CD45RA- cells to 7.6% in injured rats. When gated from
CD3-CD45RA- cells, the frequency of CD11b+CD68+
monocytes corresponded to 21% in uninjured animals.
This percentage was not significantly affected by the
induction of the injury, but was decreased to 2.8% by
clodronate injection in injured rats. Clodronate treatment
thus led to a 90% decrease of the percentage of CD3-
CD45RA-CD11b+CD68+ monocytes, relatively to the total
PBMCs, in comparison with non-depleted animals injured
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Figure 1 Liposome-encapsulated clodronate eliminates more than 80% of blood monocytes. (A) Rats received daily injections of
liposome-encapsulated clodronate starting 24 h prior to intra-muscular injection of bupivacaine until euthanasia at 4 d post-injury. Clodronate
treatment induces a decrease of the CD3-CD45RA- non-lymphoid cell frequency (A, upper lane), and of the frequency of CD11b+CD68+ monocytes
found in the CD3-CD45RA- population (A, lower lane). Gates were set using either omission of primary antibodies (omission of CD3/CD45RA or CD11b)
and using an isotype control for CD68. n = 3. (B) When expressed relatively to total PBMCs, the frequency of CD3-CD45RA-CD11b+CD68+ monocytes was
decreased by 90% by the clodronate treatment in injured animals, in comparison to uninjured (*) and injured non-depleted (#) animals.
Student’s t-test, p < 0.05. n = 3. (C) Using the same gating strategy, we shown that clodronate treatment significantly decreased the frequency
of CD3-CD45RA-CD11b+CD68+ monocytes at 2 d and 3 d by 86% and 82%, respectively in injured animals, in comparison to uninjured (*) and injured
non-depleted (#) animals. Student’s t-test, p < 0.05. n = 3.
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depletion was verified for each experience at all time
points and similar depletion levels were observed: 86%
at 2 d and 82% at 3 d (Figure 1C). Thus, the clodronate
depletion procedure was effective throughout the experi-
mental protocol.
We next characterized the effect of blood monocyte
depletion on the accumulation of M1 and M2 macrophage
subsets into TA muscle following muscle injury. Thegating strategy consisted in prior selection of myeloid cells
(CD11b+) from total cells (Figure 2A I), followed by selec-
tion of total CD68+ cells (not shown), and discrimination
of the M1 and M2 populations based on the expression
of CD163 by CD11b+CD68+ monocytes/macrophages
(Figure 2A II). Prior to injury (0 d), only a few CD11b
+CD68+CD163- (M1) and CD11b+CD68+CD163+ (M2)
macrophages were present in the TA muscle (Figure 2B
and C). In injured animals non-depleted of monocytes,
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Figure 2 Numbers of M1 and M2 macrophages in TA muscle are modified by blood monocyte depletion. Rats were treated once a day
with intravenous injection of liposome-encapsulated clodronate starting 24 h prior to injury until euthanasia at 1, 2, 3 and 4 d post-injury, for analysis
of M1 and M2 macrophage accumulation into injured muscle. (A) Gating strategy (at 3 d post-injury) in single cell suspensions from skeletal muscles
was based on omission of primary antibody for CD11b, and on isotype control stainings for CD68 and CD163 to identify M1 (CD163-) and M2
(CD163+) subsets. Liposome-encapsulated clodronate induced a significant decrease in accumulation of M1 (B) and M2 (C) macrophages at 2 d
post-injury and a significant increase in M1 macrophage number at 4 d post-injury. *Significantly different from non-depleted groups, Student’s t-test,
p < 0.05. n = at least 3, for all the time points and conditions evaluated.
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following injury, which peaked at 2 d with 3.67 × 106 M1
macrophages per muscle and then dramatically decreased
by 81% at 3 d before returning to baseline at 4 d post-
injury (Figure 2B). A similar pattern was observed with
M2 macrophages, with a peak at 2 d (2.38 × 105 M2
macrophages per muscle). However M2 macrophage
accumulation resolved more progressively than the M1
population, with a 33% decrease between 2 and 3 d, and
above baseline accumulation remaining at 4 d (Figure 2C).
When monocytes were depleted, we observed a 57% de-
crease in accumulation of M1 macrophages at 2 d post-
injury, when compared to non-depleted injured animals
(Figure 2B). Monocyte depletion had no impact on M1
macrophage number at 3 d, but it led to a 2.4-fold increaseof M1 macrophage accumulation at 4 d, when compared
with non-depleted injured rats (Figure 2B). As for the M2
macrophages, monocyte depletion induced a significant
41% decrease of their accumulation that was only detect-
able at 2 d after injury (Figure 2C). Taken together, these
results show that a 90% blood monocyte depletion only
leads to a partial (about 50%) decrease of macrophage accu-
mulation at 2 d, and causes an increase in the number of
the M1 subset at 4 d post-injury, suggesting an alternative
mechanism of accumulation besides monocyte infiltration.
Monocyte depletion is associated with proliferation of
macrophages in injured muscles
Given that profound monocyte depletion led to modest
decrease of macrophage numbers in injured muscles at
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mining if local proliferation could occur in macrophages
found within skeletal muscle. Using the gating strategy
previously described (prior gating on CD11b+ cells, from
viable cells), we then measured the proportion of M1
and M2 macrophages positive for Ki-67, which detects
proliferative cells, irrespectively of their position within
the cell cycle. In muscles of rats that were uninjured
or that were injured but not submitted to monocyte
depletion, 3.6% and 4.8% of all CD11b+CD68+ cells were
positive for Ki-67 marker, respectively. The percentage
of CD11b+CD68+Ki-67+ proliferative macrophages was
increased by 3.4-fold when injured rats were treated with
clodronate (Figure 3A). In uninjured rat muscles, the
absolute numbers of Ki-67+M1 and Ki-67+M2 macro-
phages were barely detectable at all time points tested
(Figure 3B and C). At 2 d, numbers of proliferating M1B
Uninjured
Monocyte depleted
Non-depleted
N
um
be
r 
of
 m
ac
ro
ph
ag
es
 M
1/
K
i6
7+
 (
*1
05
)
0
0.2
0.4
0.6
0.8
1.0
2d 3d 4d
Time after injury
1.2
CD68+
Non-de
A Uninjured
*
*
K
i6
7+
 (
pr
ol
ife
ra
tin
g)
 
3.6
0 102 103 104 105
0
102
103
104
105
0 102 1
0
102
103
104
105
Figure 3 Monocyte depletion induced significant increase in the num
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post-injury for analysis of the number of proliferating Ki-67+M1 and Ki-67+M2
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macrophage subsets were quantified at 2, 3 and 4 d post-injury. Liposome-en
Ki-67+M2 macrophage numbers at 4 d post-injury. *Significantly different from
time points and conditions evaluated.and M2 macrophages were respectively 6- and 7.5-fold
higher in non-depleted animals in comparison to depleted
animals (Figure 3B and C), but these absolute numbers
represented only a small fraction (approximately 1%) of
the total M1 and M2 macrophages found in tissue at this
time point under the same conditions (Figure 2B and C).
Inversely, at 4 d, monocyte depletion led to significant
16- and 10-fold increases in the numbers of proliferating
M1 and M2 macrophages (Figure 3B and C), respectively,
which correspond to 10% of total M1 and 20% of M2
macrophage populations (Figure 2B and C). There is
clearly an increased local proliferation of macrophages
following skeletal muscle injury when monocyte infil-
tration is blocked.
To rule out the contribution of resident cells to M1
and M2 macrophage accumulation following injury, we
used single leg irradiation before muscle injury. IrradiationUninjured
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depleted animals 4 d after injury, supporting that infil-
tration is the main source of accumulation and that the
population is contracting normally in those conditions
(Figure 4A). However, irradiation reduced almost com-
pletely the depletion-induced increase of M1 macrophage
number when compared to the non-depleted groups sug-
gesting the implication of a local precursor (Figure 4A).
Relatively to the uninjured group, M2 macrophages accu-A
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Figure 4 Irradiation modulates M1 and M2 macrophage accumulation
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time points and conditions evaluated.mulated in spite of irradiation in non-depleted animals
but to a lower extent than in non-irradiated/non-depleted
animals, suggesting that their accumulation relies on both
proliferation of local progenitor and an infiltrating precur-
sor (Figure 4B). With irradiation, monocyte depletion
did not induce a greater decrease in M2 macrophage
accumulation, suggesting that M2 progenitors were un-
affected when monocyte infiltration is artificially blocked
(Figure 4B). Taken together, these results suggest thatn-depleted/
irradiated
Monocyte
depleted/
irradiated
Injured
Monocyte
depleted/
non irradiated
*
n-depleted/
irradiated
Monocyte
depleted/
irradiated
Injured
Monocyte
depleted/
non irradiated
*
*
in TA muscle. Hind limb was submitted to 20 Gy 24 h before injury
intravenous injection of liposome-encapsulated clodronate starting
ers of M1 and M2 macrophages into injured muscle. (A) Irradiation
depleted. (B) Irradiation impaired the accumulation of M2 macrophages
dition homologous, Student’s t-test, p < 0.05. n = at least 3, for all the
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is mostly dependent on monocyte infiltration but that a
local progenitor can contribute when monocyte infiltration
is impaired. Conversely, M2 macrophage accumulation
relies on both infiltrating and local precursors.
The M2 Marker CD163 is not expressed by
circulating monocytes
Since an infiltrating precursor seems to participate to M2
macrophage accumulation, we verified if a monocyte sub-
set expressing CD163 marker was present in circulation.
We used the previously defined strategy where CD3-/
CD45RA- stained PBMCs were analyzed based on expres-
sion of CD11b, CD68 and CD163. Gates were based on
the omission of primary antibody for CD3/CD45RA and
CD11b while isotype controls were used for CD68 and
CD163 (Figure 5). We found that blood monocyte subset
CD3-CD45RA-CD11b+CD68+ does not express CD163
(Figure 5). Our results are in accordance with previous
literature showing that CD68 is largely used as human
and rat monocyte marker, but CD163 expressed by human
blood monocytes appears restricted to M2 macrophages
in rat [25-27]. Taken together, our results support that in
rat, circulating CD11b+CD68+ cells do not express the M2
CD163 marker.
Discussion
Macrophages adopt various phenotypes based on their
environment and participate to many physiological pro-
cesses [4,8,28,29]. Substantial efforts have been deployed
to characterize these various phenotypes with the hope
that a better understanding of macrophage subsets could
help delineate detrimental from the beneficial effects.
It is now known that both M1 and M2 macrophagesS
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Figure 5 CD68+ blood monocytes do not express CD163. Blood was is
submitted to antibody staining for flow cytometric analyses to assess CD16
using omission of primary antibody for CD3/CD45RA and for CD11b; and u
representative of 4 individual observations.positively influence myogenesis, but can also contribute to
pathological conditions [30-33]. Although mechanisms
of macrophage replenishment were described in other
tissues [34-36], the intrinsic mechanisms supporting their
accumulation in the specific context of muscle injury are
still a matter of debate and how these mechanisms are
modulated under various anti-inflammatory strategies
remains unknown. The main findings of this paper are that
following muscle injury 1) both M1 and M2 macrophages
can proliferate locally and 2) the major source of M1
macrophages are circulating precursors while M2 accu-
mulation relies about equally on local (radiation sensitive)
and infiltrating precursors. 3) We show for the first time
that proliferation of macrophages is increased under
condition of monocyte depletion.
We observed a low but quantifiable proliferation of M1
and M2 macrophage subsets following muscle injury at 2
d post-injury in non-depleted animals. This is in accor-
dance with the reported proliferative ability of a number
of macrophage subtypes including macrophages located in
brain [35,37] or peritoneum [38], bone marrow-derived
macrophages in culture [39], and the macrophage cell
line RAW-264.7 [40]. Moreover, Hashimoto et al. have
recently demonstrated that some tissue-resident macro-
phages repopulate locally via cellular proliferation with
minimal contribution from monocytes, but these findings
were observed under steady-state situation in alveolar
macrophages, which are known to possess unique features
such as a half-life 3 to 4 times longer than other macro-
phage subsets [34]. Ajami et al. also found no evidence of
microglia progenitor recruitment from the circulation,
but these results were observed in denervation and CNS
neurodegenerative disease models [35]. Macrophage pro-
liferation was also observed during chronic inflammationC
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olated from uninjured rat. Total white blood cells were collected and
3 expression on CD3-CD45RA-CD11b+CD68+ cells. Gates were set
sing isotype control staining for CD68 and CD163. Results shown are
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subsets of macrophages accumulated around collateral
vessels in spite of monocyte depletion during femoral
artery occlusion-induced arteriogenesis [42]. However,
in these studies the authors failed to discriminate the
proliferative capacity of M1 and M2 macrophages [41,42].
Jenkins et al. (2011) clearly showed that tissue macro-
phages with M2-like phenotype and M1 macrophages
can undergo proliferation, but this was done in a model
of TH-2-driven inflammation where the presence of IL-
4 was essential [15]. Thus, macrophage proliferation has
been demonstrated in various tissues and experimental
models quite distinct from the one presented here. This is
the first evidence that macrophage proliferation occurs
specifically in skeletal muscle tissue and that proliferation
contributes to macrophage accumulation following muscle
injury. Our results are therefore unique and represent, to
the best of our knowledge, the first demonstration that
proliferation of M1 and M2 macrophages normally occurs
following sterile muscle injury.
M1 macrophage accumulation
Up to now, most studies pointed toward the infiltration
of “inflammatory monocytes” to explain the accumulation
of tissue macrophages after non-infectious tissue injury
like skeletal muscle trauma. However, recent evidence
shows that macrophages can undergo local proliferation
in TH2-mediated inflammation [15]. This prompted us
to verify the effect of sustained monocyte depletion, in
an attempt to delineate if monocyte infiltration is the
sole contributor to macrophage accumulation in muscle
injury. In accordance with other studies [3,43,44], monocyte
depletion induced a significant decrease in the absolute
number of M1 macrophages present at 2 d post-injury. We
surprisingly observed a higher number of M1 macrophages
observed in the monocyte-depleted animals at 4 d post-
injury, when compared to non-depleted injured animals. It
was very unlikely that this phenomenon could be explained
by an increased recruitment at 4 d, since current literature
suggests that signals for monocyte recruitment are not
produced at this time point [2]. Importantly, numerous
reports showed delayed peaks of macrophage accumu-
lation following acute muscle injury when using diverse
anti-inflammatory strategies; our results are the first to
suggest that the mechanisms leading to this delayed
accumulation differ from that of normal accumulation
and relies on local proliferation. One could argue that
the preconditioning with clodronate has enriched the
residual monocyte population for the highly proliferative
monocytes. To verify it, we have assessed the effect of
clodronate treatment on the percentage of proliferative
monocytes into PBMCs population. We observed that
clodronate treatment tended to enrich CD11b+CD68+Ki-67+
proliferative blood monocyte population by about 2.5-foldat all time points tested in comparison to untreated animals
(data not shown). This increase represents a small absolute
percentage of proliferative monocytes into PBMCs popula-
tion (0.01% in non-treated vs. 0.025% in treated animals),
and given the short timeframe of this study, those
could have contributed partially the large increase of
CD11b+CD68+Ki-67+ proliferative macrophages observed
into muscle.
Our data strongly suggest that a precursor located
within skeletal muscles prior to injury can contribute to
M1 macrophage accumulation when monocyte infiltration
is blocked. Irradiation, which prevents replication of resi-
dent macrophages, did not have any effect on the absolute
number of M1 macrophages in non-depleted animals
following injury, suggesting that infiltration of blood-
derived monocytes was the main mechanism in those
conditions. Inversely, irradiation short-circuited the increase
of M1 macrophage number that was induced at 4 d with
continuous depletion of monocytes. We conclude that
when monocyte infiltration is artificially decreased or
delayed, an alternative mechanism based on proliferation
of a local M1 precursor is triggered to ensure the accumu-
lation of that specific subset.
M2 macrophage accumulation
Based on the present results, we conclude that M2 macro-
phage accumulation following injury relies on mixed
mechanisms involving infiltration of blood monocytes
as well as proliferation of local and radiation-sensitive
precursors. Different mechanisms have been proposed
to explain M2 macrophage accumulation; these include
a specific circulating M2 precursor (CX3CR1
hi/Ly6Clo
monocytes) [16], a switch of phenotype from M1 toward
M2 [2], and lastly, the capacity of M2 macrophages to
undergo local proliferation [15]. Data obtained in models
of muscle injury led us to originally hypothesize that
depletion of blood monocyte would eliminate M1 mac-
rophages and thus indirectly decrease the number of
M2 macrophages [2]. As predicted, CD163+ macrophage
accumulation was significantly reduced at 2 d post-injury
in monocyte-depleted animals, but this difference was
lost at later time points. In an attempt to explain this
phenomenon, we showed that irradiation had a significant
impact on the absolute number of M2 macrophages in
injured rats treated or not with clodronate. These re-
sults thus suggest that M2 macrophage accumulation is
ensured, at least partially, by a local progenitor such as
resident cells expressing M2 phenotype or resulting
from the conversion of previously infiltrated M1 mac-
rophages into M2 [7,16]. Conversely, M2 macrophage
accumulation was still significant when muscle was
irradiated, which argues against the hypothesis that
local radiation-sensitive precursors are the only source
for M2 macrophages. Overall, the data obtained by
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that different pools of infiltrating and local M2 precursors
could differently contribute to their accumulation. In
order to identify a circulating progenitor for M2 mac-
rophages, we assessed if a circulating monocyte subset
expressed the M2 marker CD163 but were unable to detect
such cells. Thus, the possibility of a CD68+CD163- precur-
sor or of an unknown circulating precursor for M2
macrophages remains open. Moreover, non-circulating
progenitor cannot be excluded since it has been shown
in brain that microglia are maintained throughout life
independently of any blood input [45].
Conclusions
In summary, the present study shows for the first time
that macrophages have the capacity to proliferate following
sterile muscle injury and that the number of proliferating
macrophages is increased within muscles when monocyte
infiltration is blocked. We conclude that under normal
physiological conditions, the main source of M1 macro-
phages is circulating monocytes while M2 macrophage
accumulation relies on both local and infiltrating pre-
cursors. As a whole, our study highlights overlapping
mechanisms involved in macrophage accumulation after
sterile skeletal muscle injury and suggests that these
mechanisms are modulated when monocyte infiltration is
impaired like is the case of anti-inflammatory conditions.
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